Our imaging and transcriptomic findings showed that, in contrast to solid tumors, chemotherapy suppressed AML cell migration, as well as provided novel insight into the role of the Rho-MRTF-SRF pathway in the migration of chemoresistant AML cells. Here, SRF is linked to acute myeloid leukemia.